Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility

Intensive Care Medicine

Volumn 32, Issue 2, 2006, Pages 260-266

  Stanilova, Spaska A ^a   Miteva, Lyuba D ^a   Karakolev, Zhivko T ^a   Stefanov, Chavdar S ^b  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Interleukin 10; Polymorphism; Severe sepsis

Indexed keywords

INTERLEUKIN 10;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICAL RESEARCH; MOLECULAR DYNAMICS; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEPSIS; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; SEPSIS; STATISTICS, NONPARAMETRIC;

EID: 32844458670     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-0022-4     Document Type: Article

References (31)

1. van Deventer SJH (2000) Cytokine and cytokine receptor polymorphism in infectious disease. Intensive Care Med 26:S98-S102
2. Stuber F (2001) Effect of genomic polymorphisms on the course of sepsis: Is there a concept for gene therapy? J Am Soc Nephrol 12:S60-S64
3. Sfeir T, Saha DC, Astiz M, Rackow EC (2001) Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 29:129-133
4. Gomez-Jimenez J, Martin MC, Sauri R, Segura RM, Esteban F, Ruiz JC, Nuvials X, Boveda JL, Peracaula R, Salgado A (1995) Interleukin-10 and the monocyte/macrophage- induced inflammatory response in septic shock. J Infect Dis 171:472-475
5. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA (1997) Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on ressistance to infection. Ann Surg 226:450-458
6. Oberholzer A, Oberholzer C, Moldawer LL (2002) Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30:S58-SS63
7. Latifi SQ, O'Riordan MA, Levine AD (2002) Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 70:4441-4446
8. Kahlke V, Dohm C, Mees T, Brotzmann K, Schreiber S, Schroder J (2002) Early interleukin-10 treatment improves survival and enhances immune function only in males after hemorrhage and subsequent sepsis. Shock 18:24-28
9. Stanilova SA, Karakolev ZT, Dimov GS, Dobreva ZG, Miteva LD, Slavov ES, Stefanov CS, Stanilov NS (2005) High interleukin-12 and low interleukin-10 production after in vitro stimulation detected in sepsis survivors. Intensive Care Med 31:401-407
10. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8
11. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P (2000) New polymorphisms in the IL-10 promoter region. Genes Immun 1:231-233
12. Eskdale J, Galager G (1995) A polymorphic dinucleotide repeat in the human IL-10 promoter region. Immunogenetics 42:444-445
13. Eskdale J, Kube D, Tesch H, Gallagher G (1997) Mapping of the human IL-10 gene and further characterization of the 5' flanking sequence. Immunogenetics 46:120-128
14. Eskdale J, McNicholl J, Wordsworth P, Jonas B, Huizinga T, Field M, Gallagher G (1998) Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 352:1282-1283
15. D'Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P (2000) Systemic lupus erythematosus candidate genes in the Italian population: Evidence for a significant association with interleukin-10. Arthritis Rheum 43:120-128
16. Lowe PR, Galley HF, Abdel-Fattah A, Webster NR (2003) Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 31:34-38
17. Schaaf BM, Boehmke F, Esnaashari H, Seitzer U, Kothe H, Maass M, Zabel P, Dalhoff K (2003) Pneumococcal septic shock is associated with the interleukin-10-1082 gene polymorphism. Am J Respir Crit Care Med 168:476-480
18. Shu Q, Fang X, Chen Q, Stuber F (2003) IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J (Engl) 116:1756-1759
19. American College of Chest Physicians/Society of Critical Medicine Consensus Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
20. Zhelev ZD, Stanilova SA, Carpenter BG (1994) Isolation, partial characterisation and complement inhibiting activity of a new glycoprotein from Cuscuta europea. Biochem Biophys Res Commun 202:186-194
21. Cavet J, Middleton P, Segal M, Noreen H, Davies S, Dickinson A (1999) Recipient tumor necrosis factor and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 94:3941-3946
22. Stanilova S, Dobreva Z, Slavov E, Miteva L (2005) C3-binding glycoprotein from Cuscuta europea induced different cytokine profiles from human PBMC compared to other plant and bacterial immunomodulators. Int Immunopharmacol 5:723-734
23. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P (1999) Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42:1101-1108
24. Paterson JCM (1999) Inherited haplotypes of the interleukin-10 promoter differentially regulate gene transcription. Joint Congress of the BSI and the BSACI, abstract OP258
25. Eskdale J, Keijsers V, Huizinga T, Gallagher G (1999) Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immunity 1:151-155
26. Keijsers V, Verweij CL, Hazes JMW, Westendorp RGJ, Breedveld FC, Huizinga TWJ (1998) Innate differences in IL-10 production are present at the level of transcription and associated with haplotypes: association of IL-10 haplotypes and rheumatoid arthritis. Clin Exp Rheumatol 16:200
27. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW (2002) The IL-10-1082 G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci 59:560-569
28. Gaston K, Fried M (1995) CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promoter of the Surf-1 and Surf-2 genes. Nucleic Acids Res 23:901-909
29. Stanilova S, Miteva L (2005) Taq-I polymorphism in 3'UTR of the IL-12 and association with IL-12p40 production from human PBMC. Genes Immun 6:364-366
30. Gogos C, Drosou E, Bassaris H, Skoutelis A (2000) Pro versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181:176-180
31. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA (1997) T-cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 158:315-321